Pluri Biotech Ltd

Pluri Biotech Ltd is an SME in Haifa, Israel that has taken part in 6 EU-funded projects since 2011, receiving €6.7M in EU funding.

EU funding received€6.7M
EU projects6
As coordinator0
Running now1
First EU project2011
Latest project2023
CountryIsrael
EU registration (PIC)984846336
On this page · 5 sections→

Where the EU money came from

Funding by EU programme. Amounts are Pluri Biotech Ltd's own share of each project, not the project's full budget.

  • Horizon 2020€6.1M · 4 projects
  • Horizon Europe€486k · 1 project
  • FP7 (2007 to 2013)€93k · 1 project

Projects

6 EU-funded projects, newest first. Each links to the official record.

  • PROTOPartner

    PROTO - Advanced PeRsOnalized Therapies for Osteoarthritis – TACKLING INFLAMMATION TO IMPROVE PATIENT OUTCOMES

    Horizon Europe · 2023–2027 · Project on CORDIS ↗

    €486ktheir share
  • RESTOREPartner

    RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients

    Horizon 2020 · 2019–2020 · Project on CORDIS ↗

    €15ktheir share
  • HIPGENPartner

    Placenta-expanded adherent stromal cells (PLX-PAD) as an innovative therapy for improving recovery and survival following hip fracture arthroplasty – HIPGEN, a multicenter phase III trial

    Horizon 2020 · 2018–2022 · Project on CORDIS ↗

    €2.5Mtheir share
  • nTRACKPartner

    Multimodal nanoparticles for structural and functional tracking of stem cell therapy on muscle regeneration

    Horizon 2020 · 2017–2022 · Project on CORDIS ↗

    €488ktheir share
  • PACEPartner

    A multicenter phase IIb study using HLA-unmatched allogeneic placenta-derived stromal cells (PLX-PAD) for the treatment of severe critical limb ischemia accompanied by mechanistic studies

    Horizon 2020 · 2017–2021 · Project on CORDIS ↗

    €3.1Mtheir share
  • MEDIAPartner

    The MEtabolic Road to DIAstolic Heart Failure

    FP7 (2007 to 2013) · 2011–2016 · Project on CORDIS ↗

    €93ktheir share

Works most with

Organisations that shared the most EU projects with this one. A good starting list for consortium partners.

Fields it works in

Research fields recorded on its Horizon projects.

  • autoimmune diseases
  • cardiology
  • cells technologies
  • diabetes
  • homeostasis
  • immunology
  • mortality
  • nanomedicine
  • nuclear medicine
  • oncology
  • personalized medicine
  • pharmaceutical drugs
  • proteins
  • public health

Is this your organisation?

Claim it with an EUACC listing (€39 once, reviewed by our editors): add what you build, your team and what you are looking for. We pre-fill it from your EU records. Listed companies reach investors through our newsletter and get matched to new EU calls first.

Claim this profile →

Source: CORDIS (Horizon Europe, Horizon 2020, FP7) and the EU Funding & Tenders Portal (other EU programmes), matched by the EU registration number (PIC). Past participation does not mean the organisation is open to new partnerships. Official website ↗

Europe’s tech funding.
One place.

The weekly briefing

Funding calls, VC news and key deadlines — a weekly briefing for European founders.

Free · unsubscribe anytime